Skip to main content
Premium Trial:

Request an Annual Quote

FDA Clears IQuum's Influenza A/B Assay

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has given 510(k) clearance to IQuum's assay for detecting and differentiating influenza A and B in about 20 minutes, the company announced today.

IQuum's Liat Influenza A/B Assay and Liat Analyzer is an automated sample-to-result multiplex real-time RT-PCR assay intended for use in CLIA-certified laboratories. According to IQuum, it is the only test that has sensitivity and specificity equivalent to or better than current lab-based nucleic acid tests, as well as time to result and ease of use comparable to immunoassays.

The assay, which is also CE marked, requires one minute of operator hands-on time and can achieve results in about 20 minutes, making it appropriate for hospital near-patient settings, the Marlborough, Mass.-based firm said.

"IQuum's goal is to provide sophisticated nucleic acid tests that can be performed in near-patient settings and deliver accurate results to physicians and patients instantly," IQuum CEO Shuqi Chen said in a statement.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.